#car-t-cell-therapy

[ follow ]
#autoimmune-diseases
from The Atlantic
1 day ago
OMG science

'We Never Dared to Think About the Cure'

Breakthroughs in CAR-T-cell therapy offer hope for lupus and autoimmune disease treatments, suggesting a potential shift towards remission and management.

Daily briefing: Believe it or not, this lush green landscape is Antarctica

Antarctica is experiencing rapid greening, indicating imminent changes in its ecosystems.

Scientists Made a CRISPR Breakthrough for Autoimmune Diseases

Promising CRISPR treatments using donor cells may revolutionize the management of autoimmune conditions for millions of Americans.

'We Never Dared to Think About the Cure'

Breakthroughs in CAR-T-cell therapy offer hope for lupus and autoimmune disease treatments, suggesting a potential shift towards remission and management.

Daily briefing: Believe it or not, this lush green landscape is Antarctica

Antarctica is experiencing rapid greening, indicating imminent changes in its ecosystems.

Scientists Made a CRISPR Breakthrough for Autoimmune Diseases

Promising CRISPR treatments using donor cells may revolutionize the management of autoimmune conditions for millions of Americans.
moreautoimmune-diseases

World-first therapy using donor cells sends autoimmune diseases into remission

Three individuals with severe autoimmune conditions achieved remission through CRISPR-modified immune cells, demonstrating potential for scalable treatment.

Fixing key flaw in revolutionary cancer treatment - Harvard Gazette

Researchers boosted CAR T-cell therapy for prolonged effectiveness.
#immunotherapy

Revolutionary CAR-T cell therapy looks to break through beyond blood cancer

CAR-T cell therapy revolutionizes blood cancer treatment by enhancing T-lymphocytes to combat tumors, with potential for wider application beyond hematological cancers.

Do cutting-edge CAR-T-cell therapies cause cancer? What the data say

CAR-T-cell therapy faces FDA investigation for potential link to lymphomas.

Revolutionary CAR-T cell therapy looks to break through beyond blood cancer

CAR-T cell therapy revolutionizes blood cancer treatment by enhancing T-lymphocytes to combat tumors, with potential for wider application beyond hematological cancers.

Do cutting-edge CAR-T-cell therapies cause cancer? What the data say

CAR-T-cell therapy faces FDA investigation for potential link to lymphomas.
moreimmunotherapy

TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers - Nature

Antibody and CAR T cell therapies show promise in treating T cell cancers
Development of antibody-drug conjugate to target TRBC1 shows potential for improved outcomes
#clinical-trial

A promising glioblastoma clinical trial: Cancer researchers say tumors dramatically shrunk

Novel cell therapy shrinks glioblastoma tumors dramatically
CAR-T cell therapy shows promising results in Phase 1 trial

Cellular Therapy Increases Survival in Recurring B-cell Lymphoma - News Center

CAR T-cell therapy shows strong safety in treating B-cell lymphoma.
Personalized cellular therapy demonstrates improved overall survival in patients.

Exploring CAR T-cell Therapy for Aggressive Follicular Lymphoma - News Center

CAR T-cell therapy shows effectiveness in treating aggressive follicular lymphoma, offering durable responses even after multiple treatments.

A promising glioblastoma clinical trial: Cancer researchers say tumors dramatically shrunk

Novel cell therapy shrinks glioblastoma tumors dramatically
CAR-T cell therapy shows promising results in Phase 1 trial

Cellular Therapy Increases Survival in Recurring B-cell Lymphoma - News Center

CAR T-cell therapy shows strong safety in treating B-cell lymphoma.
Personalized cellular therapy demonstrates improved overall survival in patients.

Exploring CAR T-cell Therapy for Aggressive Follicular Lymphoma - News Center

CAR T-cell therapy shows effectiveness in treating aggressive follicular lymphoma, offering durable responses even after multiple treatments.
moreclinical-trial

Newly found 'kill switch' triggers death of cancer cells in potential breakthrough

Researchers have identified a protein that can trigger the death of cancer cells, potentially offering a new therapeutic target.
The protein is located on the CD95 receptor, also known as Fas, and can program cancer cells to self-destruct.
Future cancer drugs could boost the activity of CD95 receptors to create a new weapon against cancer tumors.
[ Load more ]